§ 13F · FUND PROFILE
Decheng Capital LLC.
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · $396M (13F)Positions · 25Turnover · — · Q1Filed · May 13, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
No new positions
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q1 2026
FILED MAY 13, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q1 |
|---|---|---|---|---|---|---|
| 1 | CGON | CG ONCOLOGY INC | 6.37M | $431M | 65.2% | ±0% |
| 2 | NUVB | Nuvation Bio Inc. | 25.95M | $111M | 16.8% | ±0% |
| 3 | UPB | Upstream Bio Inc. | 2.72M | $25M | 3.7% | −13% |
| 4 | ACRS | Aclaris Therapeutics, Inc. | 4.04M | $15M | 2.3% | ±0% |
| 5 | AARD | AARDVARK THERAPEUTICS INC | 3.92M | $15M | 2.2% | ±0% |
| 6 | LYEL | Lyell Immunopharma, Inc. | 692K | $14M | 2.1% | ±0% |
| 7 | NAMS | NEWAMSTERDAM PHARMA CO NV | 325K | $10M | 1.6% | −45% |
| 8 | RCUS | Arcus Biosciences, Inc | 478K | $10M | 1.6% | −12% |
| 9 | RVMD | REVOLUTION MEDICINES INC(NSM) | 94K | $9M | 1.4% | −53% |
| 10 | EQ | Equillium Inc. | 4.45M | $9M | 1.3% | ±0% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE DECHENG SIGNAL
AC read
Decheng Capital LLC is a Other fund managing $396 million in assets. The fund runs a focused portfolio of just 25 positions.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
1 FILINGS
Q1 2026
Steady book
+0 buys · −0 exits · 0 changed
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed
Q2 2025
Steady book
+0 buys · −0 exits · 0 changed
Q1 2025
Steady book
+0 buys · −0 exits · 0 changed